Calbros Pharma India Private Limited
About Calbros Pharma India Private Limited
Data last updated:
Calbros Pharma India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 31 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC359570. Its GSTIN is 07AAICC5566E1ZL (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ankit Kalra (Whole-Time Director) and Sakshi Kalra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 6 Kirti Nagar, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.16 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹6.24 Cr (net margin 11.7%) and EBITDA of ₹8.74 Cr (EBITDA margin 16.4%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 91% over five years.
Company details
Contact details
Calbros Pharma India Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA – 6 Kirti Nagar, New Delhi, Delhi, India – 110015
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of Calbros Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Calbros Pharma India is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Calbros Pharma India Private Limited, buy the company report.
Financials of Calbros Pharma India Private Limited
FY 2025 filings availableCalbros Pharma India Private Limited reported revenue of ₹53.16 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 91%. EBITDA fell 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.74 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.24 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.4% | ||||
| Net Profit Margin | 11.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Calbros Pharma India Private Limited, buy the company report.
Board of directors of Calbros Pharma India Private Limited
Calbros Pharma India has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sakshi Kalra Also directs: Wellness Kart Private Limited | Director | 31 Dec 2019 | 6 Years 10 Months | Current |
| Ankit Kalra | Whole-Time Director | 31 Dec 2019 | 6 Years 10 Months | Current |
| Sanjita Kalra | Director | 28 Jan 2020 | 6 Years 9 Months | Current |
Auditor
Calbros Pharma India Private Limited is audited by ANIL KHATRI & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANIL KHATRI & CO | FY 2020 | 008469N |
Shareholding
The shareholding of Calbros Pharma India Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Calbros Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Calbros Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Calbros Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Calbros Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICC5566E1ZL | Delhi | Active | 12 Feb 2020 |
To see the full GST registrations and return filing status of Calbros Pharma India Private Limited, buy the company report.
Recent activity
Calbros Pharma India Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Sanjita Kalra was appointed as Director on 28 Jan 2020.
Frequently asked questions
Calbros Pharma India is an active private limited company based in New Delhi, Delhi, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 31 December 2019 (7+ years old) and is registered under CIN U51909DL2019PTC359570.
Calbros Pharma India has 3 current directors:
- Ankit Kalra - Whole-Time Director
- Sakshi Kalra - Director
- Sanjita Kalra - Director
The latest financial statements of Calbros Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Calbros Pharma India is 07AAICC5566E1ZL, registered in Delhi.
The CIN (Corporate Identification Number) of Calbros Pharma India is U51909DL2019PTC359570. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Calbros Pharma India was incorporated on 31 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Sanjita Kalra was appointed as Director on 28 Jan 2020. Ankit Kalra was appointed as Whole-Time Director on 31 Dec 2019. Sakshi Kalra was appointed as Director on 31 Dec 2019.
The registered office of Calbros Pharma India is at A – 6 Kirti Nagar, New Delhi, Delhi, India – 110015.
Calbros Pharma India operates in the chemicals and materials industry, in the chemical distribution and retail segment.
Calbros Pharma India can be reached at its registered office: A – 6 Kirti Nagar, New Delhi, Delhi, India – 110015.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
